Skip to main content
Clinical Trials/NCT00207610
NCT00207610
Completed
Phase 3

Phase 3 Study of the Prevention of Postpartum Anemia by Three Different Strategies

Centers for Disease Control and Prevention1 site in 1 country959 target enrollmentJune 2003
ConditionsAnemia

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Anemia
Sponsor
Centers for Disease Control and Prevention
Enrollment
959
Locations
1
Primary Endpoint
anemia
Status
Completed
Last Updated
17 years ago

Overview

Brief Summary

Anemia is common among low-income women after they have given birth. Anemia, or low hemoglobin in the blood cells, is usually caused by not having enough iron. Blood cells usually carry oxygen to other parts of the body. Without enough hemoglobin, the ability of blood cells to carry oxygen is decreased. Memory and work may be impaired. The purpose of this study is to evaluate three methods of giving iron to prevent anemia among low-income women after they have given birth.

Detailed Description

Currently the Centers for Disease Control and Prevention recommendations to prevent iron deficiency advocate selective screening and treatment of anemia at about 6 weeks postpartum. However, among some groups, such as low income women, data suggest that anemia and iron deficiency are common. This study aims to evaluate the effectiveness of three stategies to prevent iron deficiency among low income postpartum women in Mississippi. Comparisons: Clinics will be randomized to one of three strategies: 1)Selective anemia screening and treatment of anemic women, 2)universal anemia screening and treatment of anemic women, or 3)universal iron supplementation of 65 mg a day for three months.

Registry
clinicaltrials.gov
Start Date
June 2003
End Date
September 2007
Last Updated
17 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • postpartum girls and women, 2-6 weeks after birth
  • age 13 years or more
  • WIC certified

Exclusion Criteria

  • sickle cell anemia
  • Hemoglobin \< 7 g/dL

Outcomes

Primary Outcomes

anemia

Time Frame: 6 months postpartum

Study Sites (1)

Loading locations...

Similar Trials